Fumarate is known to inhibit 2OG-dependent oxygenases, including HIF-hydroxylase Phd2 (Hewitson et al., 2007), the Tet enzymes, and KDMs (Xiao et al., 2012), and as a consequence, tumor cells with FH mutations have increased HIF-1α stability and display a hypermethylator phenotype (Isaacs et al., 2005; Pollard et al., 2007; Letouzé et al., 2013; Castro-Vega et al., 2014). Here, HIF1A is linked to neoplasm.